Safety Study of Thioridazine in Combination With Cytarabine to Treat Relapsed or Refractory Acute Myeloid Leukemia

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This is a Phase I trial investigating the safety of using thioridazine in addition to cytarabine in elderly patients with relapsed or refractory Acute Myeloid Leukemia.
Epistemonikos ID: ef28da4c63f7a1ee5d85e56fd85f2dfa043b1f9f
First added on: May 11, 2024